Cosphiadi Irawan
Overview
Explore the profile of Cosphiadi Irawan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Irawan C, Nufus H, Rachmadi L, Harimurti K, Munandar A, Yunus R
Contemp Oncol (Pozn)
. 2022 Nov;
26(3):220-228.
PMID: 36381664
Introduction: The incidence of nasopharyngeal cancer (NPC) is high, with new cases accounting for 5.2% of all malignancies in Indonesia. Most cases are detected at an advanced stage, and recurrences...
12.
Putranto R, Agung R, Irawan C, Soejono C, Shatri H
Acta Med Indones
. 2022 Apr;
54(1):28-34.
PMID: 35398823
Background: The need of palliative care is increasing, but it is not all achievable. It is necessary to identify palliative patients in order to provide the proper care according to...
13.
Irawan C, Iskandar M, Harahap A, Rumende C, Ham M
Cancer Manag Res
. 2022 Mar;
14:925-935.
PMID: 35256863
Background: Treatment response in diffuse large B-cell lymphoma (DLBCL) is heterogenous. The Hans algorithm (using 30% cut-offs for CD10, BCL6, and MUM1 protein expression) has been the most favored method...
14.
Irawan C, Benbella L, Rachman A, Mansjoer A
J Epidemiol Glob Health
. 2021 Nov;
12(1):16-24.
PMID: 34846716
Objectives: The majority of patients with head and neck cancer (HNC) come to the hospital at advanced stages. This research was conducted to determine the mortality, 2-year progression-free survival (PFS)...
15.
Irawan C, Rachman A, Rahman P, Mansjoer A
J Cancer Epidemiol
. 2021 Nov;
2021:1103631.
PMID: 34751228
Background: The three-year survival rate of locally advanced nasopharyngeal carcinoma (NPC) patients in Indonesia is lower than in other Asian countries. Calculation of hemoglobin-to-platelet ratio (HPR) may become a more...
16.
Yoon S, Song Y, Kim S, Yoon D, Chen T, Koh Y, et al.
Lancet Reg Health West Pac
. 2021 Jul;
10:100126.
PMID: 34327343
Background: Peripheral T-cell lymphomas (PTCLs) are uncommon and their frequency is regionally heterogeneous. Several studies have been conducted to evaluate the clinical features and treatment outcomes of this disease entity,...
17.
Lee Y, Yoon S, Song Y, Kim S, Yoon D, Chen T, et al.
Int J Hematol
. 2021 Jul;
114(3):355-362.
PMID: 34302593
Cutaneous T-cell lymphomas (CTCLs) are a group of T-cell lymphomas with low incidence. Due to their indolent characteristics, treatment strategies have not yet been established for advanced CTCLs. In this...
18.
Syam A, Pitoyo C, Suhendro S, Zulkarnain B, Indrasari N, Aditianingsih D, et al.
Acta Med Indones
. 2021 Jul;
53(2):194-201.
PMID: 34251348
Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range...
19.
Yunir E, Kurniawan F, Rezaprasga E, Wijaya I, Suroyo I, Matondang S, et al.
Int J Stem Cells
. 2020 Dec;
14(1):21-32.
PMID: 33377454
Diabetes mellitus (DM) remains one of the most important risk factors for peripheral artery disease (PAD), with approximately 20% of DM patients older than 40 years old are affected with...
20.
Irawan C, Cahyanur R, Lisnawati L, Abdullah M, Yunus R
Acta Med Indones
. 2020 Aug;
52(2):147-154.
PMID: 32778629
Background: nasopharyngeal cancer (NPC) is the most common type of head and neck cancer in Indonesia (28.4%). Reports showed that 18.9% of cases came with advanced stage. Chemotherapy play important...